查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1654397

综合症多重诊断市场规模、份额、趋势分析报告（按类型、最终用途、地区、细分预测），2025 年至 2030 年

Syndromic Multiplex Diagnostics Market Size, Share & Trends Analysis Report By Type (Respiratory, Gastrointestinal, Central Nervous System), By End Use (Hospitals, Diagnostic Laboratories, Others), By Region And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

综合多重诊断市场的成长与趋势

根据 Grand View Research, Inc. 的一份新报告，全球症候群多重诊断市场规模预计到 2030 年将达到 36.6 亿美元，2025 年至 2030 年期间的复合年增长率为 3.91%。市场的成长归因于诊断技术的进步、各种疾病盛行率的上升、对快速准确诊断解决方案的需求不断增加以及全球人口老化等因素。

传统的诊断测试需要多个步骤并且通常需要很长时间才能产生结果，而综合多重诊断则透过在一个样本中同时测试多种病原体提供了全面的解决方案。此功能大大减少了诊断所需的时间，增加了各种需要快速诊断的医疗环境的需求。此外，呼吸系统疾病和胃肠道疾病等需要有效诊断解决方案的各种疾病的高发性也促进了市场的成长。例如，根据美国疾病管制与预防中心 (CDC) 的数据，2023 年美国诊断和记录的梅毒、淋病和披衣菌感染病例超过 240 万例。总合包括超过 209,000 例梅毒病例、超过 60 万例淋病病例和超过 160 万例披衣菌感染病例。预计此类感染疾病的高盛行率将在预测期内推动市场成长。

此外，市场参与企业不断增加的研究和开发力度也推动了新的诊断解决方案的开发，并增加了最终用户可获得的多种诊断产品。例如，2021年1月，新加坡推出了由MiRXES开发的名为「Fortitude SARS-CoV-2 & Flu A/B Test」的多重诊断套件。此测试可检测并区分 SARS-CoV-2 和甲型/乙型流感，从而提供更准确的诊断。该套件已获得新加坡卫生科学局（HSA）的临时批准。预计开发此类可提供更好结果的有效解决方案将增加这些解决方案的采用，从而推动市场成长。

对就地检验(POCT) 的需求不断增长也促进了市场的成长。随着对快速诊断的需求不断增加，特别是在偏远和服务不足的地区，多重诊断系统透过在单次测试中同时检测多种病原体和疾病而提供了显着的优势。此外，亚洲、拉丁美洲、中东和非洲等地区正致力于改善其医疗保健基础设施，促进采用能够提供更快、更准确结果的综合诊断系统。

综合多重诊断市场报告重点

  • 按类型划分，呼吸系统疾病将在 2024 年占据最大的市场占有率。这是由于各种呼吸道感染疾病的发生率不断增加以及有效诊断技术的日益普及。
  • 根据最终用途，诊断实验室部门在 2024 年占据最大的市场占有率。这是因为这些设施的患者流动率高且可及性强。
  • 根据地区划分，北美将占据市场主导地位，到 2024 年将占 41.85% 的份额。由于主要市场参与企业的存在、不断变化的监管环境、不断改善的医疗保健基础设施以及各种感染疾病的流行日益加剧，北美综合征多重诊断行业正在经历显着增长。

目录

第一章调查方法与范围

第 2 章执行摘要

3. 综合多重诊断市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 综合多重诊断市场分析工具
    • 产业分析 – 波特五力分析
    • PESTEL 分析

第 4 章 综合多重诊断市场类型、估计与趋势分析

  • 细分仪表板
  • 症候群多重诊断市场：类型变异分析
  • 2018 年至 2030 年综合多重诊断市场规模及趋势分析（按类型）
  • 呼吸系统
  • 胃肠道
  • 中枢神经系统
  • 其他类型的综合征（cUTI 和 STD）

第 5 章 综合多重诊断市场：依最终用途的估计与趋势分析

  • 细分仪表板
  • 综合多重诊断市场：最终用途变异分析
  • 2018 年至 2030 年综合多重诊断市场规模及趋势分析（依最终用途）
  • 医院
  • 诊断实验室
  • 其他的

第六章 综合多重诊断市场：按地区分類的估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 市场规模、预测趋势分析，2018-2030
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商概况
    • 主要经销商及通路伙伴名单
    • 2023 年主要企业的市场占有率分析
    • Abbott Laboratories
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche Ltd
    • Qiagen
    • bioMerieux
    • DiaSorin SpA（Luminex Corporation）
    • Hologic, Inc.
    • Becton, Dickinson and Company（BD）
    • Applied BioCode
    • QIAGEN
    • Curetis GmbH
Product Code: GVR-4-68040-507-5

Syndromic Multiplex Diagnostics Market Growth & Trends:

The global syndromic multiplex diagnostics market size is anticipated to reach USD 3.66 billion by 2030, and it is expected to expand at a CAGR of 3.91% from 2025 - 2030, according to a new report by Grand View Research, Inc. The market's growth is attributed to factors such as technological advancements in diagnostics technologies, rising prevalence various diseases, growing demand for rapid and accurate diagnostics solutions, and global aging population.

Traditional diagnostic tests often require multiple steps and take longer to deliver results, whereas syndromic multiplex diagnostics offer a comprehensive solution by testing for multiple pathogens simultaneously in a single sample. This capability significantly reduces the time for diagnosis, increasing their demand in various healthcare settings where rapid diagnostics are preferred. Moreover, the high prevalence of various conditions, such as respiratory diseases, gastrointestinal conditions, and others, requiring effective diagnostics solutions further contributes to the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2023, more than 2.4 million instances of syphilis, gonorrhea, and chlamydia were diagnosed and documented in the U.S. This total includes over 209,000 syphilis cases, over 600,000 gonorrhea cases, and more than 1.6 million chlamydia cases. This high prevalence of infectious diseases is expected to fuel the market growth over the forecast period.

Moreover, the increasing R&D efforts by market players are leading to the development of new diagnostics solutions, increasing the availability of multiple diagnostics products for the end users. For instance, in January 2021, Singapore launched the Fortitude SARS-CoV-2 & Flu A/B Test, a multiplex diagnostic kit developed by MiRXES. This test detects and differentiates SARS-CoV-2 and influenza A/B, providing more accurate diagnoses. The kit received Provisional Authorisation from Singapore's Health Sciences Authority (HSA). The development of such effective solutions offering better results is expected to increase the adoption of these solutions and drive market growth.

The growing demand for Point-of-Care Testing (POCT) also contributes to market growth. With the rise in the demand for rapid diagnosis, especially in remote or underserved regions, multiplex diagnostic systems offer significant advantages by allowing for the simultaneous detection of multiple pathogens or diseases with a single test. Additionally, focuses on improving the healthcare infrastructure in regions such as Asia, Latin America and MEA are encouraging the implementation of integrated diagnostic systems that can provide faster and more accurate results.

Syndromic Multiplex Diagnostics Market Report Highlights:

  • Based on type, the bipolar respiratory segment held the largest market share in 2024. This is attributed to the rising prevalence of various respiratory infections and rising availability of effective diagnostics technologies.
  • Based on end use, the diagnostics laboratories segment held the largest market share in 2024. This is attributed to the high patient footfall in these facilities and their better accessibility to patients.
  • Based on region, North America dominated the market and accounted for a 41.85% share in 2024. The syndromic multiplex diagnostics industry in North America is experiencing significant growth driven by the presence of key market players, evolving regulatory landscape, developed healthcare infrastructure, and increasing prevalence of various infectious diseases.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Syndromic Multiplex Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of infectious diseases
      • 3.2.1.2. Advancements in diagnostics technologies
      • 3.2.1.3. Growing demand for effective diagnostics solutions
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of syndromic diagnostics solutions
  • 3.3. Syndromic Multiplex Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Syndromic Multiplex Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Syndromic Multiplex Diagnostics Market: Type Movement Analysis
  • 4.3. Syndromic Multiplex Diagnostics Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Respiratory
    • 4.4.1. Respiratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Gastrointestinal
    • 4.5.1. Gastrointestinal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Central Nervous System
    • 4.6.1. Central Nervous System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Other Types of Syndromes (cUTI and STDs)
    • 4.7.1. Other Types of Syndromes (cUTI and STDs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Syndromic Multiplex Diagnostics Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Syndromic Multiplex Diagnostics Market: End Use Movement Analysis
  • 5.3. Syndromic Multiplex Diagnostics Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Diagnostic Laboratories
    • 5.5.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Syndromic Multiplex Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/Reimbursement
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/Reimbursement
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/Reimbursement
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/Reimbursement
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/Reimbursement
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/Reimbursement
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/Reimbursement
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/Reimbursement
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/Reimbursement
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/Reimbursement
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/Reimbursement
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/Reimbursement
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/Reimbursement
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/Reimbursement
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/Reimbursement
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/Reimbursement
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/Reimbursement
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/Reimbursement
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/Reimbursement
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/Reimbursement
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/Reimbursement
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/Reimbursement
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Abbott Laboratories
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Services benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Thermo Fisher Scientific, Inc.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Services benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. F. Hoffmann-La Roche Ltd
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Services benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Qiagen
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Services benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. bioMerieux
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Services benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. DiaSorin S.p.A (Luminex Corporation)
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Services benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Hologic, Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Services benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Becton, Dickinson and Company (BD)
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Services benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Applied BioCode
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Services benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. QIAGEN
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Services benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Curetis GmbH
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Services benchmarking
      • 7.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America syndromic multiplex diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Mexico syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 10 Mexico syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe syndromic multiplex diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 12 Europe syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 13 Europe syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Germany syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 15 Germany syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 16 UK syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 17 UK syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 18 France syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 19 France syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Italy syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 21 Italy syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Spain syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 23 Spain syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Denmark syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 25 Denmark syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Sweden syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 27 Sweden syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Norway syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 29 Norway syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific syndromic multiplex diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 33 China syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 34 China syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Japan syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 36 Japan syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 India syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 38 India syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 39 South Korea syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 40 South Korea syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Australia syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 42 Australia syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Thailand syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 44 Thailand syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 46 Latin America syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Brazil syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 48 Brazil syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Argentina syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 50 Argentina syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 51 MEA syndromic multiplex diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 52 MEA syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 53 MEA syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 54 South Africa syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 55 South Africa syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 58 UAE syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 59 UAE syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Kuwait syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 61 Kuwait syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Syndromic multiplex diagnostics market: market outlook
  • Fig. 14 Syndromic multiplex diagnostics competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Syndromic multiplex diagnostics market driver impact
  • Fig. 20 Syndromic multiplex diagnostics market restraint impact
  • Fig. 21 Syndromic multiplex diagnostics market strategic initiatives analysis
  • Fig. 22 Syndromic multiplex diagnostics market: Type movement analysis
  • Fig. 23 Syndromic multiplex diagnostics market: Type outlook and key takeaways
  • Fig. 24 Respiratory market estimates and forecasts, 2018 - 2030
  • Fig. 25 Gastrointestinal market estimates and forecasts, 2018 - 2030
  • Fig. 26 Central nervous system market estimates and forecasts, 2018 - 2030
  • Fig. 27 Other types of syndromes (cUTI and STDs) market estimates and forecasts, 2018 - 2030
  • Fig. 28 Syndromic multiplex diagnostics market: End Use movement analysis
  • Fig. 29 Syndromic multiplex diagnostics market: End Use outlook and key takeaways
  • Fig. 30 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 31 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 32 Others market estimates and forecasts, 2018 - 2030
  • Fig. 33 Global syndromic multiplex diagnostics market: Regional movement analysis
  • Fig. 34 Global syndromic multiplex diagnostics market: Regional outlook and key takeaways
  • Fig. 35 Global syndromic multiplex diagnostics market share and leading players
  • Fig. 36 North America market share and leading players
  • Fig. 37 Europe market share and leading players
  • Fig. 38 Asia Pacific market share and leading players
  • Fig. 39 Latin America market share and leading players
  • Fig. 40 Middle East & Africa market share and leading players
  • Fig. 41 North America, by country
  • Fig. 42 North America
  • Fig. 43 North America market estimates and forecasts, 2018 - 2030
  • Fig. 44 U.S. key country dynamics
  • Fig. 45 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 46 Canada country dynamics
  • Fig. 47 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 48 Mexico country dynamics
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 50 Europe
  • Fig. 51 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 52 UK country dynamics
  • Fig. 53 UK market estimates and forecasts, 2018 - 2030
  • Fig. 54 Germany
  • Fig. 55 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 56 France country dynamics
  • Fig. 57 France market estimates and forecasts, 2018 - 2030
  • Fig. 58 Italy country dynamics
  • Fig. 59 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 60 Spain country dynamics
  • Fig. 61 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 62 Denmark country dynamics
  • Fig. 63 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 64 Sweden country dynamics
  • Fig. 65 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 66 Norway country dynamics
  • Fig. 67 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 68 Asia Pacific
  • Fig. 69 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 70 China country dynamics
  • Fig. 71 China market estimates and forecasts, 2018 - 2030
  • Fig. 72 Japan country dynamics
  • Fig. 73 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 74 India country dynamics
  • Fig. 75 India market estimates and forecasts, 2018 - 2030
  • Fig. 76 Thailand country dynamics
  • Fig. 77 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 78 South Korea country dynamics
  • Fig. 79 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 80 Australia country dynamics
  • Fig. 81 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 82 Latin America
  • Fig. 83 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 84 Brazil country dynamics
  • Fig. 85 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 86 Argentina country dynamics
  • Fig. 87 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 88 Middle East and Africa
  • Fig. 89 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 90 South Africa country dynamics
  • Fig. 91 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 92 Saudi Arabia country dynamics
  • Fig. 93 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 94 UAE country dynamics
  • Fig. 95 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 96 Kuwait country dynamics
  • Fig. 97 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 98 Market share of key market players - Syndromic multiplex diagnostics market, 2023
  • Fig. 99 Company Categorization